US · biotechnology · pharmaceutical
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · Apr 2025 · $70M
Forbion lead, Sanofi Ventures lead, Novartis Venture Fund, Versant Ventures
Reported by Silicon Canals
Missing a round, or an investor who was in one? Tell us.